Oninvest

🏗️ A consortium led by JPMorgan and MUFG is reportedly arranging $38B in debt financing for Vantage Data Centers to build two Oracle-linked campuses in Texas and Wisconsin, expanding Oracle’s cloud for AI workloads, including support for OpenAI operations.

🍾 #AAL rose 5.6% after lifting its 2025 EPS outlook to $0.65–$0.95, up from prior guidance of a loss to $0.80 profit. The airline cited strong demand for premium travel — with perks like Lavazza coffee and Bollinger champagne boosting revenue mix.

#INTC jumped 8% after posting its first quarterly profit since late 2023 and beating forecasts with $13.7B revenue (+3% YoY) and $0.23 EPS. Strong PC chip demand lifted results, but investors remain focused on whether Intel’s foundry business can attract major third-party clients

🚀 SpaceX’s latest Starlink satellites reportedly support the same radio spectrum used by iPhones, The Information says — sparking talk of a possible future link-up with Apple, which currently relies on Globalstar for satellite connectivity.

Power-systems maker Vicor soars on strong, AI-boosted earnings and analyst upgrades – Oninvest Quotes of Vicor Corporation, which makes modular power components and complete power systems, jumped 30% yesterday, October 22, after the company reported quarterly results that beat Wall Street exp...

⚡️ #VICR, a power-systems maker for chips and data centers, beat Q3 estimates with $110M revenue (+18.5% YoY) and $0.63 EPS, driven by AI demand and rising licensing income. Here’s more on the company’s future plans that could spark further growth: en.oninvest.com/article/powe...

🧠 Quantum computing stocks surged after WSJ reported the U.S. government is exploring taking equity stakes in key firms as part of a new tech funding plan. #IONQ, #RGTI, and #QBTS jumped 12–14% on the news.

Citigroup upgrades rating, TP on obesity drugmaker BioAge amid upcoming clinical data – Oninvest Citigroup has upgraded to "buy" shares of small-cap obesity drug developer BioAge Labs, calling the company’s lead molecule promising, with the first-in-human study recently announced . The upgrade se...

Citigroup upgraded #BIOA to Buy from Hold and raised its target to $10, citing strong potential for its obesity drug BGE-102, an NLRP3 inhibitor now in early human trials, details: en.oninvest.com/article/citi...

🛰️ Airbus, Thales, and Leonardo will merge their satellite divisions into Project Bromo, a €6.5 B venture with 25K staff.
Set to begin operations in 2027, it aims to build a European rival to SpaceX, pending EU approval.

📄Revolut has obtained a crypto asset license from Cyprus’s regulator, allowing it to offer digital-asset services across the EU, per Reuters.

The fintech began crypto trading in 2017 and launched Revolut X in 2024, now licensed under new EU MiCA rules.

#IBM beat Q3 expectations with EPS $2.65 vs $2.45 est. and revenue $16.33 B vs $16.09B est., up 9% YoY.

The firm lifted its 2025 outlook to >5% revenue growth and ~$14B free cash flow.

AI order book hit $9.5 B, but shares slipped as growth in its cloud unit slowed.

🤳 #Reddit has filed a lawsuit against Perplexity AI in New York, accusing the startup and its partners — Oxylabs, AWMProxy, and SerpApi — of illegally harvesting Reddit posts to train AI models. #Perplexity denies using Reddit data and says it will fight the allegations.

🛢️Oil jumped after the U.S. imposed sanctions on Russia’s oil giants #Rosneft and #Lukoil, sending Brent crude up ~5% and prompting Indian refiners to review Russian crude imports.

The EU also adopted its 19th sanctions package, adding a phased LNG ban and other new restrictions.

#AAPL will sharply scale back production of its ultra-thin iPhone Air to under 10% of launch levels amid weak demand, as buyers favor the iPhone 17 line.

Musk is also pushing a $1T pay package, hinting he could leave if not granted more control.

🚗Tesla Q3 revenue rose 12% YoY to $28.1 B, beating estimates ($26.4 B) amid a pre–tax–credit buying rush.

EPS missed ($0.50 vs $0.54 est.) as carbon-credit sales fell 44% and operating costs surged 50%.

Net income declined 37% to $1.37 B. $TSLA slid 4% after hours.

Minerva soars 140% on up to $200 mln raise to finish schizophrenia drug trial – Oninvest Quotes of Minerva Neurosciences, a micro-cap developer of a drug against negative symptoms in patients with schizophrenia, soared 140% in one day. The company, which is worth just $44.8 million on th...

💊 #NERV announced up to $200M in new funding to advance Phase 3 trials of roluperidone — its drug for negative symptoms of schizophrenia. If results are positive, #Minerva plans to resubmit to the FDA and prep for a U.S. launch. en.oninvest.com/article/mine...

'Symbol of rebellion': Beyond Meat stock rockets 466% in two days – Oninvest A short squeeze and social media campaigns by retail investors are behind it

🥩 #BYND soared 466% in two days and jumped another 90% premarket after being added to the Roundhill Meme Stock ETF and expanding its Walmart deal. A short squeeze fueled the rally, but Wall St. remains bearish with a $2.33 avg target. More: en.oninvest.com/article/symb...

🚖Nebius Group and Uber will invest up to $375M in Avride, an autonomous driving company within Nebius Group based in Austin, Texas, to expand its robotaxi fleet, enhance AI tech, and scale delivery under an expanded Uber partnership.

🚖Nebius Group and Uber will invest up to $375M in Avride, an autonomous driving company within Nebius Group based in Austin, Texas, to expand its robotaxi fleet, enhance AI tech, and scale delivery under an expanded Uber partnership.

💄 L’Oréal ( #OR.PA) slid ~6% after Q3 sales rose 4.2% to €10.33 B, missing the 4.9% estimate. While China saw its first growth in two years, weak U.S. and Latin America results weighed. RBC and Barclays called the update “disappointing,” citing limited clarity on future growth.

💄 #LVMH is reportedly considering selling its 50% stake in #FentyBeauty, the hit cosmetics brand it co-founded with Rihanna. The brand made about $450M in 2024 and could be valued at $1–2B. The potential sale comes as LVMH trims its portfolio following recent fashion pullbacks.

🤖Prince Harry and Meghan Markle joined AI pioneers in signing an open letter calling for a ban on developing “superintelligent” AI until it’s proven safe and controllable.

Harry warned that “AI should serve humanity, not replace it,” urging global restraint in tech progress.

⚡️Unions and corporate watchdogs launched the “Take Back Tesla” campaign, urging shareholders to reject Elon Musk’s $1T pay package. Proxy firms ISS & Glass Lewis also oppose it over dilution and governance risks, while ARK’s Cathie Wood defends Musk ahead of the Nov 6 vote.

a black background with red letters that say netflix ALT: a black background with red letters that say netflix

🎬 #NFLX slid ~6% after Q3 EPS came in at $5.87 vs est. $6.96, with operating margin at 28% vs est. 31.5%, hit by a $619M Brazil tax charge. Revenue rose 17% to $11.51B, in line with forecasts; another 17% YoY gain is expected in Q4 on new releases and record ad sales.

🇪🇺🇺🇦 Europe and Ukraine are drafting a 12-point plan to freeze the war along current front lines, per Bloomberg.

The White House, meanwhile, said there are no near-term plans for a Trump-Putin meeting, despite earlier reports of talks in Budapest.

The board is weighing whether to sell outright or proceed with its planned 2026 split into two companies. #WBD jumped ~12% on the news.

🎬 Warner Bros. Discovery is exploring a full sale amid unsolicited interest from major buyers, reportedly including Netflix and Comcast. The company earlier rejected a ~$20/share offer from Paramount-Skydance as too low.

🚗 #GM soared ~15% — its best one-day jump in 5 years — after hiking its 2025 outlook. The automaker now expects $12–13B EBIT and up to $10.5 EPS, driven by strong SUV and truck demand. Analysts see strength as GM adapts to new U.S. policies.

#GM #Autos #Markets

The Motley Fool spotlights mid-cap luxury goods retailer RH for patient investors – Oninvest Investors with a long-term horizon should take a closer look at shares of luxury home goods seller RH, writes Jeremy Bowman, an analyst at the Motley Fool. The company has faced a number of challenge...

🏠 Motley Fool’s Jeremy Bowman says patient investors should take another look at #RH. Despite a 54% YTD drop, Q2 net income surged 79% and net revenue rose 8.4%. Expansion into Europe and new ventures could fuel a comeback as housing improves. More: en.oninvest.com/article/the-...

The Motley Fool spotlights mid-cap luxury goods retailer RH for patient investors – Oninvest Investors with a long-term horizon should take a closer look at shares of luxury home goods seller RH, writes Jeremy Bowman, an analyst at the Motley Fool. The company has faced a number of challenge...

🏠 Motley Fool’s Jeremy Bowman says patient investors should take another look at #RH. Despite a 54% YTD drop, Q2 net income surged 79% and net revenue rose 8.4%. Expansion into Europe and new ventures could fuel a comeback as housing improves. More: en.oninvest.com/article/the-...